Provoked Vestibulodynia and Topical Treatment: A New Option.

Healthcare (Basel)

Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation, 27100 Pavia, Italy.

Published: April 2022

Background: Provoked vestibulodynia is commonly associated with dyspareunia and affects 7% to 15% of women. This pathology has major implications on sexual function and quality of life, and several types of treatments are available for its management. However, a consensus has not been reached concerning the best treatment of vulvar pain. The aim of this study was to assess the efficacy and safety of a brand-new product, the vulvar emulgel Meclon Lenex, for the management of provoked vestibulodynia and non-infective vulvitis.

Methods: This was a monocentric, prospective, randomized, double-blind and placebo-controlled study. We enrolled 40 women with provoked vestibulodynia; 20 patients received Meclon Lenex, whereas the remaining received a placebo. Each woman was assessed subjectively (through questionnaires) and objectively by evaluating vaginal and vulvar symptoms (Friedrichs criteria and Marinoff dyspareunia grade). We evaluated efficacy, safety, compliance and tolerability of the brand-new product vulvar gel Meclon Lenex in provoked vestibulodynia.

Results: After administration of Meclon Lenex, we evaluated all parameters of the Friedrichs criteria (burning, dyspareunia, erythema, vulvar pain at the 5 o'clock position and 7 o'clock position), as well as the levels of Marinoff dyspareunia. The active treatment showed to be statistically significantly effective ( value ≤ 0.05) in reducing all symptoms of Friedrichs criteria, vulvar pain and Marinoff dyspareunia.

Conclusion: This prospective study showed that Meclon Lenex vulvar emulgel revealed an excellent tolerability and compliance, demonstrating to be a safe and effective option in the treatment of provoked vestibulodynia and non-infective vulvitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142053PMC
http://dx.doi.org/10.3390/healthcare10050830DOI Listing

Publication Analysis

Top Keywords

provoked vestibulodynia
20
meclon lenex
20
vulvar pain
12
friedrichs criteria
12
efficacy safety
8
brand-new product
8
product vulvar
8
vulvar emulgel
8
vestibulodynia non-infective
8
symptoms friedrichs
8

Similar Publications

Localized provoked vulvodynia (LPV), also called vulvar vestibulitis or provoked vestibulodynia, is a major cause of dyspareunia that severely impacts sexual health. At the tissue level, lymphocytic inflammation and hyperinnervation are characteristic pathological features, explaining the main symptoms and signs. A recent experimental animal study suggests that the histopathological findings of LPV may be due to mucosal CD4 Th17 immune responses to microbial antigens.

View Article and Find Full Text PDF

Background: The nature of pelvic floor muscle (PFM) involvement in provoked vestibulodynia (PVD) is poorly understood.

Aim: We aimed to determine if PFM electromyographic (EMG) activity in anticipation of or response to pressure applied to the posterior vaginal fourchette differs between those with and without PVD, and if the magnitude of PFM response is associated with pressure pain sensitivity, psychological or psychosexual function.

Methods: This was an observational case-control study.

View Article and Find Full Text PDF

Background: The neuromuscular contribution to increased tone of the pelvic floor muscles (PFMs) observed among those with provoked vestibulodynia (PVD) is unclear.

Aim: To determine if PFM activity differs between those with provoked PVD and pain free controls, and if the extent of PFM activation at rest or during activities is associated with pain sensitivity at the vulvar vestibule, psychological, and/or psychosexual outcomes.

Methods: This observational case-control study included forty-two volunteers with PVD and 43 controls with no history of vulvar pain.

View Article and Find Full Text PDF

Introduction: Localized provoked vulvodynia is a common sexual health condition for which there is a lack of consensus on effective management, even though it can have a significant negative impact on psychological wellbeing, sexual functioning, and quality of life for women and their partners.

Aim: To map the research landscape related to the effectiveness/efficacy of psychological treatments for localized provoked vulvodynia, identify gaps, and make recommendations for future research.

Methods: We used Arksey and O'Malley's approach to conducting a scoping review to identify, organize, and summarize research published between 2010 and 2023 that investigated the efficacy or effectiveness of interventions in the management of localized provoked vulvodynia.

View Article and Find Full Text PDF
Article Synopsis
  • Internet-based Acceptance and Commitment Therapy (ACT) can help reduce pain during intercourse and increase pain acceptance in individuals with provoked vulvodynia, but it is unclear what factors affect these outcomes.
  • This study aimed to uncover the factors influencing changes in pain acceptance after an ACT-based internet treatment, using data from a larger trial.
  • Results indicated that participants with a history of physical violence or sexual assault showed more improvement, and greater engagement with the treatment platform correlated with better outcomes; however, these findings lost significance after adjusting for multiple tests.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!